- Home
- NVCT vs BLFY Comparison
NVCT vs BLFY Comparison
Compare NVCT & BLFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- BLFY
- Stock Information
- Founded
- NVCT 2020
- BLFY 1939
- Country
- NVCT United States
- BLFY United States
- Employees
- NVCT N/A
- BLFY N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- BLFY Commercial Banks
- Sector
- NVCT Health Care
- BLFY Finance
- Exchange
- NVCT Nasdaq
- BLFY Nasdaq
- Market Cap
- NVCT 167.0M
- BLFY 185.3M
- IPO Year
- NVCT 2022
- BLFY N/A
- Fundamental
- Price
- NVCT $6.71
- BLFY $8.24
- Analyst Decision
- NVCT Strong Buy
- BLFY Hold
- Analyst Count
- NVCT 3
- BLFY 1
- Target Price
- NVCT $15.33
- BLFY $10.00
- AVG Volume (30 Days)
- NVCT 114.1K
- BLFY 43.4K
- Earning Date
- NVCT 11-05-2025
- BLFY 10-29-2025
- Dividend Yield
- NVCT N/A
- BLFY N/A
- EPS Growth
- NVCT N/A
- BLFY N/A
- EPS
- NVCT N/A
- BLFY N/A
- Revenue
- NVCT N/A
- BLFY $44,731,000.00
- Revenue This Year
- NVCT N/A
- BLFY $19.02
- Revenue Next Year
- NVCT N/A
- BLFY $17.51
- P/E Ratio
- NVCT N/A
- BLFY N/A
- Revenue Growth
- NVCT N/A
- BLFY 11.52
- 52 Week Low
- NVCT $4.44
- BLFY $8.17
- 52 Week High
- NVCT $11.80
- BLFY $11.38
- Technical
- Relative Strength Index (RSI)
- NVCT 61.14
- BLFY 35.26
- Support Level
- NVCT $5.61
- BLFY $8.51
- Resistance Level
- NVCT $7.00
- BLFY $8.65
- Average True Range (ATR)
- NVCT 0.34
- BLFY 0.23
- MACD
- NVCT 0.09
- BLFY -0.02
- Stochastic Oscillator
- NVCT 79.14
- BLFY 7.87
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About BLFY Blue Foundry Bancorp
Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.